Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis
<p>Abstract</p> <p>Background</p> <p>Interleukin-7 (IL-7) acts primarily on T cells to promote their differentiation, survival, and homeostasis. Under disease conditions, IL-7 mediates inflammation through several mechanisms and cell types. In humans, IL-7 and its recep...
Saved in:
Main Authors: | Willis Cynthia R (Author), Seamons Audrey (Author), Maxwell Joe (Author), Treuting Piper M (Author), Nelson Laurel (Author), Chen Guang (Author), Phelps Susan (Author), Smith Carole L (Author), Brabb Thea (Author), Iritani Brian M (Author), Maggio-Price Lillian (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-1 receptor blockade in perinatal brain injury
by: Jason eRosenzweig, et al.
Published: (2014) -
Loss of intestinal sympathetic innervation elicits an innate immune driven colitis
by: Rose A. Willemze, et al.
Published: (2019) -
Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
by: Hana Malcova, et al.
Published: (2021) -
Soluble interleukin-2 receptors in ulcerative colitis
by: O. H. Nielsen, et al.
Published: (1993) -
Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection
by: Yasu-Taka Azuma, et al.
Published: (2011)